The mid-term effect of SARSCOV-2 on immune-oncology checkpoint inhibitors disruption in people living with HIV - Crespo-Bermejo, C; Brochado-Kith, O; Grande-Garcia, S; Lara-Aguilar, V; Llamas-Adan, M; Arca-Lafuente, S; Martin-Carbonero, L; de los Santos, I; Jimenez Sousa, M A; Resino, S; Madrid, R; Fernandez-Rodriguez, A; et al. (Hiv Medicine, 2023)